A
Accipiter Biosciences designs and develops novel, single-agent protein therapies engineered to address complex diseases. Their platform uses computational design to create customizable, multifunctional proteins that activate multiple cell-surface receptors simultaneously. This approach offers a streamlined alternative to traditional combination therapies by integrating several therapeutic mechanisms into one stable biologic molecule.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Accipiter Biosciences designs and develops *de novo* protein therapies engineered to address complex diseases by engaging multiple molecular pathways within a single biologic agent. Their computational platform rapidly creates customizable, multifunctional proteins capable of acting as agonists to activate cell surface receptors simultaneously. This approach offers a streamlined alternative to traditional combination therapies for challenging indications like autoimmune disorders and cancer.